INFINITY PHARMACEUTICALS INC's ticker is INFI and the CUSIP is 45665G303. A total of 131 filers reported holding INFINITY PHARMACEUTICALS INC in Q3 2015. The put-call ratio across all filers is 0.76 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2017 | $0 | – | 26 | 0.0% | 0.00% | – |
Q3 2017 | $0 | -100.0% | 26 | -98.3% | 0.00% | – |
Q2 2017 | $2,000 | -60.0% | 1,501 | +1.8% | 0.00% | – |
Q1 2017 | $5,000 | +150.0% | 1,475 | +6.7% | 0.00% | – |
Q4 2016 | $2,000 | 0.0% | 1,382 | -10.3% | 0.00% | – |
Q3 2016 | $2,000 | 0.0% | 1,540 | 0.0% | 0.00% | – |
Q2 2016 | $2,000 | -77.8% | 1,540 | -6.6% | 0.00% | – |
Q1 2016 | $9,000 | -35.7% | 1,648 | -7.4% | 0.00% | – |
Q4 2015 | $14,000 | -6.7% | 1,780 | 0.0% | 0.00% | – |
Q3 2015 | $15,000 | – | 1,780 | +4464.1% | 0.00% | – |
Q2 2015 | $0 | -100.0% | 39 | 0.0% | 0.00% | – |
Q1 2015 | $1,000 | 0.0% | 39 | 0.0% | 0.00% | – |
Q4 2014 | $1,000 | 0.0% | 39 | 0.0% | 0.00% | – |
Q3 2014 | $1,000 | – | 39 | 0.0% | 0.00% | – |
Q2 2014 | $0 | -100.0% | 39 | -97.4% | 0.00% | -100.0% |
Q4 2013 | $21,000 | +31.2% | 1,500 | +50.0% | 0.00% | 0.0% |
Q2 2013 | $16,000 | – | 1,000 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
SPHERA FUNDS MANAGEMENT LTD. | 1,476,000 | $819,180 | 0.18% |
BVF INC/IL | 6,353,645 | $3,526,273 | 0.15% |
Gratus Capital, LLC | 1,323,598 | $734,600 | 0.06% |
Bleichroeder LP | 250,000 | $138,750 | 0.03% |
PLATINUM INVESTMENT MANAGEMENT LTD | 545,508 | $302,757 | 0.01% |
Callan Capital, LLC | 158,500 | $87,968 | 0.01% |
Polar Capital Holdings Plc | 2,071,242 | $1,149,539 | 0.01% |
Virtu Financial LLC | 66,537 | $37 | 0.01% |
BRIDGEWAY CAPITAL MANAGEMENT, LLC | 249,000 | $138,195 | 0.00% |
Pacific Sage Partners, LLC | 17,500 | $9,713 | 0.00% |